электронные сигареты атомайзеры

Perceptive Advisors closes $515M fund to fuel more early-stage biotech startups


Perceptive Advisors has $515 million for its second fund investing in biotech startups. Portfolio Manager Chris Garabedian says Perceptive Xontogeny Ventures Fund II is looking to make Series A investments in early-stage companies with assets that can show a path to clinical testing.

[fixed][/fixed]